RetiredCareSourcePolicy N/A

Trigger Point Injections

Defines medical necessity criteria, documentation and payment rules for trigger point injections (anesthetic and/or corticosteroid) for back pain, neck pain, and myofascial pain syndrome for CareSource Arkansas PASSE; includes limits on frequency, documentation requirements, and billing guidance.

Policy Summary

PayerCareSource

PolicyTrigger Point Injections

Policy CodePolicy N/A

Change TypeRetired (archived 2026-03-31)

Effective DateMay 1, 2025

Next Review Date

Key ActionDocument history and physical exam leading to diagnosis, reason for TPI selection, affected muscles, muscles injected and number, injection frequency, medication name, prior treatment results, and corroborating evidence of medical necessity.

SourceLink

POLICY UPDATE CHANGES

Policy archived and no longer active as of 2026-03-31.

Annual review updated references (02/28/2024) and committee approval; review updated references (02/12/2025).

8Max reimbursable dates of service per year

>=50%Required improvement to justify repeat injection

3 monthsPain onset window for 'new' localized pain

1 monthMinimum conservative therapy trial before initial TPI

Coverage Summary

coverage_stance: covered_with_criteria; subject: Trigger Point Injections (TPIs); scope_summary: Defines medical necessity criteria, documentation, frequency limits, and billing guidance for trigger point injections (anesthetic and/or corticosteroid) for back pain, neck pain, and myofascial pain syndrome for CareSource Arkansas PASSE.; status: RETIRED; effective: 2025-05-01; issued: 2023-05-10; last_review: 2025-02-12; archived: 2026-03-31.

Medical Necessity Criteria

Trigger Point Injections - Initial Injection (Medically Necessary Criteria)

Trigger point injections of anesthetic and/or corticosteroid for back pain, neck pain, or myofascial pain syndrome are considered medically necessary when pain has persisted despite appropriate medical management and ALL the following criteria are met:

ALL of the following

Member presents with new (acute or subacute) localized pain, occurring in the last 3 months.Timeframe: last 3 months

Policy Summary

PayerCareSource

PolicyTrigger Point Injections

Policy CodePolicy N/A

Change TypeRetired (archived 2026-03-31)

Effective DateMay 1, 2025

Next Review Date

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Trigger Point Injections - Subsequent Injections

Criteria and limits for repeating trigger point injections:

ALL of the following

Trigger point injections should be repeated only if reasonable and medically necessary.
No more than 8 dates of service per calendar year per member may be reimbursed.<= 8 dates/year
Maximum reimbursable dates of service per year
Injections may be repeated only with documentation supporting a positive result at the last trigger point injection involving the anatomic site, including at least 50% improvement in pain, functioning, and activity tolerance.>= 50% improvement
Required improvement to justify repeat injections

ref_orig

ref_original

ref_duplicate

ref

ref2

ref3

ref4

ref5

Provider Actions & Billing Guidance

Documentation Required

Required documentation for initial TPI

Document history and physical exam leading to diagnosis, reason for TPI selection, affected muscles, muscles injected and number, injection frequency, medication name, prior treatment results, and corroborating evidence of medical necessity.

Proper evaluation including a patient history and physical examination leading to diagnosis of the trigger point
Reason(s) for selecting trigger point injection as the therapeutic option
Affected muscle or muscles
Muscle or muscles injected and the number of injections
Frequency of injections required
Name of the medication used in the injection
Results of any prior treatment
Corroborating evidence that the injection is medically necessary

Prior Authorization

Frequency limit enforcement

Do not expect reimbursement for more than 8 dates of service per calendar year; repeat injections require documentation of >=50% improvement at last injection for that anatomic site.

Maximum reimbursable dates of service: no more than 8 dates of service per calendar year per member
Response requirement for repeat injections: documentation of at least 50% improvement in pain, functioning, and activity tolerance at the last injection for that anatomic site

Billing Rule

Unit of service and office visit billing

Certain procedure codes specify number of injection sites; payment may be made for 1 unit of service of the appropriate procedure code per patient per date; office visit on same date is not payable unless E/M shows separate service (use modifier).

Follow procedure code guidance — some codes specify number of injection sites and the unit of service differs from number of injections
Payment: generally 1 unit of service of the appropriate procedure code per patient per date
Office visit billing: same-date office visit is not payable unless evaluation and management is separately indicated (append appropriate modifier on E/M code)

Billing Rule

Stand-alone service

A trigger point injection is normally considered a stand-alone service; bill with appropriate modifiers to indicate separate E/M if applicable.

TPIs are typically stand-alone; do not bill separate office visit payment on same date unless E/M clearly represents a separate service
When E/M is separate, append the appropriate modifier to the E/M claim to indicate distinct service

Denial Risk

Imaging/localization and dry needling exclusions

Claims for localization imaging associated with trigger point injections and claims for dry needling as an alternative to TPIs will not be covered.

Localization techniques to image or otherwise identify trigger point anatomic locations are not indicated and will not be covered when associated with TPIs.
Dry needling is not an acceptable alternative to trigger point injections by an appropriately licensed clinician and will not be covered.

Background

Background: Myofascial trigger points are self-sustaining, hyper‑irritable foci in skeletal muscle that produce referred pain patterns and comprise single‑muscle myofascial pain syndromes. The purpose of a trigger point injection (TPI) is to treat both symptom and cause by injecting a local anesthetic alone or with corticosteroid into the affected muscle to alleviate inflammation and pain.

Rationale and role: Interventional procedures, including TPIs, should be part of a comprehensive pain management plan that incorporates an initial trial of conservative treatments (eg, medications, physical therapy modalities, behavioral support) and are intended for management of pain unresponsive to conservative care.

Practice requirements: TPIs should follow a trial of conservative therapies (for example, at least 1 month of conservative measures and presentation of new localized pain within the last 3 months when applicable) and must be performed only by qualified healthcare providers acting within their scope of practice. Documentation must include evaluation/history and physical exam, reason for TPI selection, affected muscle(s), muscles injected and number, injection frequency, medication name, prior treatment results, and corroborating evidence of medical necessity.

OpenPayer

Trigger Point Injections

Coverage Summary

Medical Necessity Criteria

Not Indicated / Not Covered

Provider Actions & Billing Guidance

Coding

Background

Revision History